The preclinical natural history of serous ovarian cancer: defining the target for early detection.

by Patrick O Brown, Chana Palmer
Published 2009-07-01

Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.

by Anne L Estep, Chana Palmer, Frank McCormick, Katherine A Rauen
Published 2007-12-01

Development of the human infant intestinal microbiota.

by Chana Palmer, Elisabeth M Bik, Daniel B DiGiulio, David A Relman, Patrick O Brown
Published 2007-07-01

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.

by Sahar Houshdaran, Sarah Hawley, Chana Palmer, Mihaela Campan, Mari N Olsen, Aviva P Ventura, Beatrice S Knudsen, Charles W Drescher, Nicole D Urban, Patrick O Brown, Peter W Laird
Published 2010-02-01

Systematic evaluation of candidate blood markers for detecting ovarian cancer.

by Chana Palmer, Xiaobo Duan, Sarah Hawley, Nathalie Scholler, Jason D Thorpe, Rob A Sahota, May Q Wong, Andrew Wray, Lindsay A Bergan, Charles W Drescher, Martin W McIntosh, Patrick O Brown, Brad H Nelson, Nicole Urban
Published 2008-07-01

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

by Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput, Leah M Prentice, Dianne Miller, Jennifer Santos, Kenneth Swenerton, C Blake Gilks, David Huntsman
Published 2008-12-01